Female reproduction and type 1 diabetes: From mechanisms to clinical findings
Author
dc.contributor.author
Codner Dujovne, Ethel
Author
dc.contributor.author
Merino, P. M.
Author
dc.contributor.author
Tena-Sempere, M.
Admission date
dc.date.accessioned
2019-03-11T13:19:35Z
Available date
dc.date.available
2019-03-11T13:19:35Z
Publication date
dc.date.issued
2012
Cita de ítem
dc.identifier.citation
Human Reproduction Update, Volumen 18, Issue 5, 2018, Pages 568-585
Identifier
dc.identifier.issn
13554786
Identifier
dc.identifier.issn
14602369
Identifier
dc.identifier.other
10.1093/humupd/dms024
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/165664
Abstract
dc.description.abstract
Background: The functional reproductive alterations seen in women with type 1 diabetes (T1D) have changed as therapy has improved. Historically, patients with T1D and insufficient metabolic control exhibited a high prevalence of amenorrhea, hypogonadism and infertility. This paper reviews the impact of diabetes on the reproductive axis of female T1D patients treated with modern insulin therapy, with special attention to the mechanisms by which diabetes disrupts hypothalamic-pituitary-ovarian function, as documented mainly by animal model studies. Methods: A comprehensive MEDLINE search of articles published from 1966 to 2012 was performed. Animal model studies on experimental diabetes and human studies on T1D were examined and cross-referenced with terms that referred to different aspects of the gonadotropic axis, gonadotrophins and gonadal steroids. Results: Recent studies have shown that women with T1D still display delayed puberty and menarche, menstrual irregularities (especially o